Print this page    •   Back to Web version of article

International News
Indonesia in Bold Move to Obtain Cheap Drugs for HIV

October 16, 2012

On September 3, Indonesia's government quietly issued an order to override patents on seven important medicines used to treat individuals with HIV and hepatitis B, which will allow more inexpensive versions to be manufactured by local pharmaceutical companies. There appeared to be no protest from the pharmaceutical giants, who in the past would have defended their patents very aggressively. The drug patents belong to Merck, GSK, Bristol-Myers Squibb, Abbott, and Gilead. The drugs include Glaxo 's Abacavir, Abbott's Kaletra, and Gilead's tenofovir (Viread) which treats hepatitis B as well as providing the primary prevention treatment for those whose partners are HIV positive.

Indonesia's HIV incidence rate is not particularly high -- UNICEF estimates that nearly 310,000 individuals are infected -- but it does have the fourth highest population in the world and the virus continues to spread. Only approximately 23,000 of the 70,000 individuals infected with HIV who need drug treatment are getting it.

Back to other news for October 2012

Excerpted from:
The Guardian (London)
10.11.2012; Sarah Boseley




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/69440/indonesia-in-bold-move-to-obtain-cheap-drugs-for-h.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.